Octapharma AB (manufacturer responsible for manufacturing in bulk, primary packaging, batch release)

The drug is used for replacement therapy in adults, children, and adolescents with primary immunodeficiency syndrome, hypogammaglobulinemia, as well as for certain infections in the context of chronic lymphocytic leukemia, multiple myeloma, or after stem cell transplantation.

Dosage form: solution for injection

ATC: J06BA01